Division of Infectious Diseases, MetroHealth Medical Center, Cleveland, OH 44109, USA.
Curr HIV/AIDS Rep. 2011 Sep;8(3):164-71. doi: 10.1007/s11904-011-0080-x.
Kidney disease remains a prominent complication of HIV disease, despite beneficial effects of antiretroviral therapy on the natural history of HIV-associated nephropathy, and on kidney function in general populations of HIV infected patients. Persons of African descent continue to bear a disproportionate burden of severe kidney disease, as is true for the general population. Recently identified genetic variants in the apolipoprotein L1 gene may contribute to this burden. As is also true for the general population, markers of kidney disease, including microalbuminuria, are sensitive predictors of cardiovascular disease and mortality among persons living with HIV. The emerging experience with kidney transplantation also suggests this to be a viable option in selected patients.
尽管抗逆转录病毒疗法对 HIV 相关性肾病的自然病程以及一般 HIV 感染患者的肾功能有有益影响,但肾脏疾病仍然是 HIV 患者的一个突出并发症。非洲裔人群与一般人群一样,仍然承受着严重肾脏疾病的不成比例负担。最近在载脂蛋白 L1 基因中发现的遗传变异可能导致了这种负担。与一般人群一样,包括微量白蛋白尿在内的肾脏疾病标志物也是 HIV 感染者心血管疾病和死亡的敏感预测指标。肾脏移植的新经验也表明,在某些患者中,这是一种可行的选择。